Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank29
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-14.39M
↓ 27% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-11.34M
Historical baseline
PeriodValueYoY Change
TTM$-14.39M-13.4%
2024$-12.69M-6.2%
2023$-11.95M+39.0%
2022$-19.59M-24.5%
2021$-15.73M-177.0%
2020$-5.68M-6.4%
2019$-5.34M-0.5%
2018$-5.31M-